CVSCVS HEALTH Corp
Retail-Drug Stores And Proprietary Stores
- Revenue
- $402.1B
- 7.8% YoY
- Operating margin
- 1.2%
- 49% YoY
- EBITDA
- $9.3B
- 29% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 5.2×
- $48.1B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear602% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear32% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear34% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $292.1B | $322.5B | $357.8B | $372.8B | $402.1B | 7.8% |
| Operating income | $13.3B | $8.0B | $13.7B | $8.5B | $4.7B | 45% |
| Net income | $8.0B | $4.3B | $8.3B | $4.6B | $1.8B | 62% |
| Operating cash flow | $18.3B | $16.2B | $13.4B | $9.1B | $10.6B | 17% |
| Capex | $2.5B | $2.7B | $3.0B | $2.8B | $2.8B | 1.8% |
| Stock-based comp | $484M | $447M | $588M | $540M | $535M | 0.9% |
| Buybacks | $0 | $3.5B | $2.0B | $3.0B | $0 | 100% |
| Dividends | $2.6B | $2.9B | $3.1B | $3.4B | $3.4B | 0.7% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
No pay-versus-performance disclosure yet.